Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000542 |
Recruitment Status :
Completed
First Posted : October 28, 1999
Last Update Posted : July 29, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiovascular Diseases Coronary Disease Diabetes Mellitus Heart Diseases Hypercholesterolemia Hypertension Myocardial Infarction Myocardial Ischemia Heart Failure | Drug: Inhibitors, ACE Drug: amlodipine Drug: lisinopril Drug: doxazosin Drug: chlorthalidone Drug: pravastatin Behavioral: diet, fat-restricted | Phase 3 |

Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Primary Purpose: | Prevention |
Study Start Date : | August 1993 |
Actual Primary Completion Date : | March 2002 |
Actual Study Completion Date : | March 2002 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years to 100 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000542
OverallOfficial: | Barry Davis | University of Texas |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00000542 |
Other Study ID Numbers: |
85 P20RR011104 ( U.S. NIH Grant/Contract ) |
First Posted: | October 28, 1999 Key Record Dates |
Last Update Posted: | July 29, 2016 |
Last Verified: | February 2009 |
Cardiovascular Diseases Myocardial Infarction Heart Diseases Coronary Disease Myocardial Ischemia Hypercholesterolemia Infarction Ischemia Vascular Diseases Pathologic Processes Necrosis Hyperlipidemias Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases |
Amlodipine Lisinopril Chlorthalidone Doxazosin Pravastatin Angiotensin-Converting Enzyme Inhibitors Antihypertensive Agents Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Vasodilator Agents Anticholesteremic Agents Hypolipidemic Agents |